{
  "trial_id": "NCT00147069",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Recruitment Methods",
      "label": "met",
      "evidence": "Volunteer subjects (healthy non-smokers and healthy smokers) will be recruited from within the National Heart and Lung Institute."
    },
    {
      "criterion": "Medical History and Physical Examination",
      "label": "met",
      "evidence": "A full medical history and physical examination (including height and weight) will be performed on the initial screening visit, in addition to that recorded in the clinical case notes."
    },
    {
      "criterion": "Respiratory Assessments",
      "label": "met",
      "evidence": "Forced Expiratory Volume per second (FEVI) will be measured using a dry wedge spirometer (Vitalograph, Buckingham, UK)"
    },
    {
      "criterion": "Sputum Induction",
      "label": "met",
      "evidence": "The subject will inhale 3.5% saline at room temperature, nebulised via a De Vilbiss 99 Ultrasonic nebuliser set"
    },
    {
      "criterion": "Venous Blood Sampling",
      "label": "met",
      "evidence": "Fifty (50) millilitres of blood shall be venesected at the study visit."
    }
  ],
  "exclusion": [
    {
      "criterion": "Asthmatic patients with FEV1 less than 40% predicted value",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Alcohol abuse",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "The patient has a history of asthma and is currently using inhaled corticosteroid (ICS) and fluticasone 500 mcg/salmeterol 50 mcg. However, he has recently doubled his oral corticosteroids, which may affect the assessment.",
  "_meta": {
    "topic_id": "23",
    "trial_id": "NCT00147069",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}